| Updated in 1/6/2019 7:47:23 PM |
Viewed: 276 times |
(Journal Article) |
Presse medicale (Paris, France : 1983) 42 (9 Pt 1): 1251-8 (2013)
[Antithrombotic therapy and pregnancy].
Céline Chauleur
,
Tiphaine Raia
,
Jean-Christophe Gris
ABSTRACT
The incidence of venous thromboembolism (VTE) during pregnancy is about one event per 1000 pregnancies and placenta-mediated pregnancy complications (PC) occurred in 15%. Knowing the biological combined with clinical risk factors would help to prevent problems during the pregnancy. Several antithrombotic therapies exist, including very recent ones but LMWH and aspirin are still molecules of choice. The women should be assessed for VTE and PC risk in order to improve the outcome.